Evaluation of Rezum Therapy As a Minimally Invasive Modality for Management of Benign Prostatic Hyperplasia: A Prospective Observational Study. Arch Ital Urol Androl 2023, 95 (4). https://doi.org/10.4081/aiua.2023.12026.